Search results
Misleading Claims on Well-Known Rare Risk of AstraZeneca COVID-19 Vaccine - FactCheck.org
FactCheck.org· 4 days agoA rare risk of dangerous blood clots associated with the AstraZeneca COVID-19 vaccine was identified and reported in early 2021. This month, the company announced it was pulling the vaccine ...
Health Care Up as Vaccine Makers Gain - Health Care Roundup
Market Watch· 4 days agoHealth-care companies rose as reported cases of bird flu in Australia and the U.S. buoyed vaccine makers. Shares of CureVac, BioNTech and Moderna rose by 10%...
Vaccine makers receive stock boost after third human bird flu case in US
Newsweek· 4 days agoShares in some companies that produce vaccines have seen stock boosts following a small number of...
Nvidia Rocks, Stocks Lost in the Light, Fed Minutes Takeaways, Solomon's Song
TheStreet.com· 4 days agoMarkets appeared to be less than fully prepared that 'various [Fed] participants' had at least...
Moderna Was Among The Best Performing Large-Cap Stocks Last Week (May 20-May 26, 2024): Are They In...
Benzinga· 17 hours agoAre they in your portfolio? First Solar, Inc. FSLR shares jumped 41.5% possibly in response to...
The West should be on a war footing for the next pandemic
The Telegraph via Yahoo News· 5 days agoPeople have been quick to forget how bad the pandemic was, but it’s important to remember the scale...
3 Blue-Chip Stocks Set to Triple Soon
InvestorPlace via Yahoo Finance· 7 days agoInvestors should have a wide range of companies in multiple sectors within their investment portfolio. But the backbone of any resilient portfolio that...
Explainer-What Are the FLiRT COVID Variants and Are They More Contagious?
US News & World Report· 3 days agoThe moniker FLiRT is an acronym for the locations of the mutations the variants share on the virus' spike protein. One of them, called KP.2, has become the most commonly circulating variant ...
Novavax awaits FDA decision on whether its next COVID shot can be offered in US
Reuters via Yahoo News· 2 days agoNovavax will only be able to offer a COVID-19 vaccine in the United States this autumn if regulators...
Arbutus, Novavax See Activist Investor Action
Barrons.com· 2 days agoMcElhaugh’s statement that Arbutus doesn’t anticipate further at-the-market share issuances this year due to its substantial cash balance and liquidity....
